Critical Diagnostics Announces Cardiac Biomarker Soluble ST2 Shows Significant Clinical Value Over Natriuretic Peptide Markers in Monitoring Hospitalized Heart Failure Patients

NEW YORK--(BUSINESS WIRE)--Critical Diagnostics announced today the publication of a key research paper identifying the clinical value of the cardiac biomarker soluble ST2 (sST2) as a tool to monitor patients hospitalized for heart failure.